← FDA DRUG APPROVALS

FDA ANDA · ANDA086167

ISOSORBIDE DINITRATE

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA086167
TYPE
ANDA
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ISOSORBIDE DINITRATEDiscontinued
ISOSORBIDE DINITRATE 20MG · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 44AP
1995-02-15Manufacturing (CMC) · Supplement 43AP
1992-04-03Manufacturing (CMC) · Supplement 40AP
1992-04-03Manufacturing (CMC) · Supplement 37AP
1992-03-16Labeling · Supplement 38AP
1991-11-01Labeling · Supplement 36AP
1991-09-10Manufacturing (CMC) · Supplement 35AP
1990-07-25Labeling · Supplement 33AP
1990-07-25Labeling · Supplement 45AP
1990-03-07Labeling · Supplement 32AP
1987-04-01Manufacturing (CMC) · Supplement 30AP
1986-09-19Manufacturing (CMC) · Supplement 27AP
1986-09-19Manufacturing (CMC) · Supplement 26AP
1984-07-13Manufacturing (CMC) · Supplement 22AP
1983-12-15Manufacturing (CMC) · Supplement 21AP
1983-12-15Manufacturing (CMC) · Supplement 20AP
1982-07-20Manufacturing (CMC) · Supplement 15AP
1982-07-20Manufacturing (CMC) · Supplement 12AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →